Caris Life Sciences (CAI) Interest Expenses (2024 - 2026)

Caris Life Sciences' Interest Expenses history runs 3 years deep, the most recent figure standing at $12.8 million for Q1 2026.

• On a quarterly basis, Interest Expenses changed 0.21% year-over-year to $12.8 million in Q1 2026; TTM through Mar 2026 was -$1.9 million, a 112.52% decrease from a year earlier, with the FY2025 full-year figure at $410.4 million, down 2.65% from the prior year.
• Interest Expenses advanced to $12.8 million in Q1 2026 per CAI's latest filing, from -$2.0 million in the prior quarter.
• Across five years, Interest Expenses topped out at $450.5 million in Q3 2025 and bottomed at -$25.5 million in Q4 2024.
• The 3-year median for Interest Expenses is $13.2 million (2024), against an average of $103.1 million.
• Across the five-year window, Interest Expenses surged 3164.46% in 2025 and advanced 0.21% in 2026, its largest moves.
• Year by year, Interest Expenses stood at -$25.5 million in 2024, then jumped by 92.24% to -$2.0 million in 2025, then surged by 747.9% to $12.8 million in 2026.
• Per Business Quant, the three latest CAI Interest Expenses figures stand at $12.8 million (Q1 2026), -$2.0 million (Q4 2025), and $450.5 million (Q3 2025).